Kura Oncology, Inc. (KURA)
8.805
+0.24
(+2.86%)
USD |
NASDAQ |
Jun 09, 16:00
8.805
0.00 (0.00%)
After-Hours: 17:42
Kura Oncology EPS Diluted (Quarterly) : -0.8276 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.182 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Exelixis, Inc. | 0.7873 |
| Gilead Sciences, Inc. | 1.612 |
| Capricor Therapeutics, Inc. | -0.591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.33M |
| Revenue (Quarterly) | 18.26M |
| Total Expenses (Quarterly) | 91.60M |
| Enterprise Value | 203.26M |
| Gross Profit Margin (Quarterly) | 96.62% |
| Profit Margin (Quarterly) | -401.5% |
| Earnings Yield | -38.02% |
| Normalized Earnings Yield | -38.02 |